Alloplastic bone replacement in resection defects of the long bones

Zeitschrift für Orthopädie und ihre Grenzgebiete
O LembckeA Rüter

Abstract

Tumor endoprosthesis first have been used for replacement of pathologic lesions of the proximal and distal femur or humerus. Since the development of segmental defect prosthesis and modular tumor endoprosthesis it is possible to replace neoplastic lesions of long bones with diaphyseal parts. Review of our clinic experience involving 46 cases of prosthetic replacement and only one case with a second procedure showed that this is a more viable concept than open reduction and internal fixation with methylmethacrylate supplementation.

Citations

Feb 1, 2013·European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society·S F BaumbachI Uçkay

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

The Journal of the American Academy of Orthopaedic Surgeons
F J Frassica, Deborah A Frassica
Canadian Journal of Surgery. Journal Canadien De Chirurgie
J Schatzker, G B Ha'Eri
Journal of Long-term Effects of Medical Implants
Vasileios I SakellariouPanayiotis J Papagelopoulos
© 2021 Meta ULC. All rights reserved